Medicine

Kadcyla 160mg Injection

Ado-trastuzumab emtansine (160mg) Allopathy

Kadcyla 160mg Injection is a allopathy containing Ado-trastuzumab emtansine (160mg), made by Roche Products India Pvt Ltd. It belongs to the Anti Neoplastics group of medicines. Like most prescription medicines, it works best when every dose is taken on time, exactly as your doctor prescribed - DailyDawa can send a WhatsApp reminder for each dose and alert a family member if one is missed.

Composition
Ado-trastuzumab emtansine (160mg)
Manufacturer
Roche Products India Pvt Ltd
Type
Allopathy
Pack size
vial of 1 Injection
Therapeutic class
Anti Neoplastics
Chemical class
Monoclonal antibody (mAb)
Habit forming
No

Uses

Early Breast cancerMetastatic breast cancer

Common side effects

TirednessNauseaMusculoskeletal (bone, muscle or joint) painBleedingLow blood plateletsHeadacheLiver disorderConstipationNosebleeds

Reference information only - not medical advice. Always follow your doctor’s instructions for what to take and when.

Chat with us